Will mRNA Technology Companies Spawn Innovation Ecosystems?

Publikation: Bidrag til tidsskriftTidsskriftartikelForskning

  • Christoph Grimpe
  • Minssen, Timo
  • William Nicholson Price II
  • Ariel Stern
The mRNA technologies that helped rapidly create effective Covid-19 vaccines could become technology platform businesses, which has tremendous implications for players the world of drug development. These platforms could attract other companies interested in exploiting their advantages to develop other drugs. But all the stakeholders — platform owners, external pharmaceutical and biotech companies, policymakers, and regulators — will have to make a variety of choices.
OriginalsprogEngelsk
TidsskriftHarvard Business Review
ISSN0017-8012
StatusUdgivet - 18 apr. 2022

ID: 279498395